Kirkland & Ellis advised V-Wave Ltd., a privately held company focused on developing innovative treatment options for patients with heart failure, on its acquisition by Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for an upfront payment of $600 million, subject to customary adjustments, with the potential for additional regulatory and commercial milestone payments up to approximately $1.1 billion. V-Wave will join Johnson & Johnson as part of Johnson & Johnson MedTech. The transaction was announced August 20, 2024. Read the transaction press release The Kirkland team was led by corporate partners Lauren Colasacco, Daniel Wolf and Jimin He; and tax partner Sara Zablotney.